Literature DB >> 8299666

Minoxidil sulphation in human liver and platelets. A study of interindividual variability.

G M Pacifici1, R Bigotti, G Marchi, L Giuliani.   

Abstract

Minoxidil requires to be sulphated to exert its hypotensive effect. We report on interindividual variability in the rate of minoxidil sulphation in 118 specimens of human liver and in platelets obtained from 100 healthy subjects and 100 newborns. The frequency distribution histogram of the hepatic activity of minoxidil sulphotransferase was positively skewed; the mean was 631 pmol.min-1 x mg-1. After logarithmic transformation of the enzyme activity, the frequency distribution histogram became symmetrical and did not significantly deviate from normality. The rate of minoxidil sulphation was not different in platelets from adults (0.74 pmol.min-1 x mg-1) and newborns (1.16 pmol.min-1 x mg-1). The frequency distribution histograms were positively skewed and the results of normal equivalent deviation analysis was compatible with the presence of at least two subgroups of sulphotransferase in liver and platelets. Thus, two phenotypes of sulphotransferase exist in human liver and platelets, and the "extensive sulphator" phenotype contributes to skewing the frequency distribution. In platelets, the percentage of subjects that fall in the two subgroups is different at birth and in adulthood. This can explain the different shape of the frequency distribution in newborn and adult platelets and suggests that platelet minoxidil sulphotransferase undergoes modification after birth.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8299666     DOI: 10.1007/BF00265951

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  30 in total

1.  Dopamine sulphotransferase is better developed than p-nitrophenol sulphotransferase in the human fetus.

Authors:  M Cappiello; L Giuliani; A Rane; G M Pacifici
Journal:  Dev Pharmacol Ther       Date:  1991

2.  Differential distribution of phenol and catechol sulphotransferases in human liver and intestinal mucosa.

Authors:  M Cappiello; L Giuliani; G M Pacifici
Journal:  Pharmacology       Date:  1990       Impact factor: 2.547

3.  Dose-response study of topical minoxidil in male pattern baldness.

Authors:  E A Olsen; E R DeLong; M S Weiner
Journal:  J Am Acad Dermatol       Date:  1986-07       Impact factor: 11.527

4.  Pharmacologic properties of minoxidil: a new hypotensive agent.

Authors:  D W DuCharme; W A Freyburger; B E Graham; R G Carlson
Journal:  J Pharmacol Exp Ther       Date:  1973-03       Impact factor: 4.030

5.  Metabolism of minoxidil, a new hypotensive agent II: biotransformation following oral administration to rats, dogs, and monkeys.

Authors:  R C Thomas; H Harpootlian
Journal:  J Pharm Sci       Date:  1975-08       Impact factor: 3.534

6.  Human liver phenol sulfotransferase: assay conditions, biochemical properties and partial purification of isozymes of the thermostable form.

Authors:  N R Campbell; J A Van Loon; R M Weinshilboum
Journal:  Biochem Pharmacol       Date:  1987-05-01       Impact factor: 5.858

7.  Inheritance of human platelet thermolabile phenol sulfotransferase (TL PST) activity.

Authors:  R A Price; N J Cox; R S Spielman; J A Van Loon; B L Maidak; R M Weinshilboum
Journal:  Genet Epidemiol       Date:  1988       Impact factor: 2.135

8.  Sulfotransferase in humans: development and tissue distribution.

Authors:  G M Pacifici; M Franchi; C Colizzi; L Giuliani; A Rane
Journal:  Pharmacology       Date:  1988       Impact factor: 2.547

9.  Interindividual variability in the glucuronidation and sulphation of ethinyloestradiol in human liver.

Authors:  A Temellini; L Giuliani; G M Pacifici
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

10.  Phenol sulfotransferase in humans: properties, regulation, and function.

Authors:  R M Weinshilboum
Journal:  Fed Proc       Date:  1986-07
View more
  3 in total

1.  Testosterone sulphation and glucuronidation in the human liver: interindividual variability.

Authors:  G M Pacifici; A Gucci; L Giuliani
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jul-Sep       Impact factor: 2.441

2.  Ritodrine sulphation in the human liver and duodenal mucosa: interindividual variability.

Authors:  G M Pacifici; M C Quilici; B Giulianetti; R Spisni; M Nervi; L Giuliani; R Gomeni
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Jan-Mar       Impact factor: 2.441

3.  Human liver budesonide sulphotransferase is inhibited by testosterone and correlates with by testosterone sulphotransferase.

Authors:  G M Pacifici; M A Ferroni; A Temellini; A Gucci; M C Morelli; L Giuliani
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.